324 - Hypofractionated IMRT and Weekly Cisplatin in Patients with Stage IIB and IIIB-C1 Cervix Cancer: A Phase I/II Study - The HYPOTHESIS Trial

09:20am - 09:25am ET

Room 256

Presenter(s)

Heloisa de Andrade Carvalho, MD, PhD - University of São Paulo, Sao Paulo, Sao Paulo